Alessandra M. Bini, Ph.D.
Center to Reduce Cancer Health Disparities
National Cancer Institute
6116 Executive Blvd., Suite 602
Rockville, MD 20852
phone: (301) 435-9049
fax: (301) 435-9225
Alessandra Bini, Ph.D., is a Program Director in the Diversity Branch, Center for Cancer Health Disparities (CRCHD) at the National Cancer Institute, NIH. Prior to that Dr. Bini served as the Scientific Review Officer (SRO) for the Nuclear Dynamics and Transport (NDT) Study Section and for the Cell Biology and Development (F05) and Technology Development (F14) Fellowship Study Sections at the Center for Scientific Review (2006-2010). Earlier, she served as SRO in the review branches of the National Institute on Aging and the National Heart, Lung and Blood Institute.
Prior to her appointment at CRCHD, Dr. Bini was Associate Laboratory Member at the Lindsley F. Kimball Research Institute of the New York Blood Center (NYBC). Her research focused on the interaction of the matrix metalloproteinases system with the fibrinolytic system relevant in thrombosis, atherosclerosis, angiogenesis and inflammation. She participated in the scientific review process for agencies such as the American Institute for Biological Sciences (AIBS, US Army) and the VA Merit Review Boards.
Dr. Bini received her Ph.D. in Pathobiology and Molecular Medicine from Columbia University in New York (1986) for work on the role of thrombosis in the progression of human atherosclerosis. She also received a Dr. Biol. Sci. degree from the University of Milano, Italy and trained and specialized in Pharmacology in the Thrombosis Laboratory at Mario Negri Institute, Milano, which pioneered new studies on the interaction between thrombosis and cancer and in the Thrombosis and Vascular Biology Center at the University of Leuven (Belgium). As part of her Dr. Biol. Sci. degree she studied behavioral-cognitive psychology and received further training in counseling at the Italian Association for Demographic Education. Dr. Bini was Head of the Coagulation and Fibrinolysis Research Unit at Consorzio Mario Negri Sud, Italy and a Visiting Scientist at the New York Blood Center (1998-1992).